Digital PCR assessment of MGMT promoter methylation coupled with reduced protein expression optimises prediction of response to alkylating agents in metastatic colorectal cancer patients.
暂无分享,去创建一个
A. Bardelli | F. D. De Braud | F. Di Nicolantonio | M. Nichelatti | A. Sartore-Bianchi | S. Siena | M. Milione | L. Barault | F. Pietrantonio | A. Cassingena | S. Ghezzi | A. Amatu | A. Pellegrinelli | F. Tosi | M. Caporale | R. Berenato | C. Falcomata | C. Falcomatà
[1] M. Esteller,et al. Tumor MGMT promoter hypermethylation changes over time limit temozolomide efficacy in a phase II trial for metastatic colorectal cancer. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.
[2] Y. Ba,et al. MGMT in colorectal cancer: a promising component of personalized treatment , 2016, Tumor Biology.
[3] C. Cordon-Cardo,et al. Immunopathologic Assessment of PTEN Expression. , 2016, Methods in molecular biology.
[4] F. D. De Braud,et al. Dose-Dense Temozolomide in Patients with MGMT-Silenced Chemorefractory Colorectal Cancer , 2016, Targeted Oncology.
[5] M. Esteller,et al. Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[6] J. J. van den Oord,et al. MGMT promoter methylation is associated with temozolomide response and prolonged progression‐free survival in disseminated cutaneous melanoma , 2015, International journal of cancer.
[7] C. Marquette,et al. Discrepancies between FISH and immunohistochemistry for assessment of the ALK status are associated with ALK 'borderline'-positive rearrangements or a high copy number: a potential major issue for anti-ALK therapeutic strategies. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[8] N. Ishii,et al. Immunohistochemical evaluation of O6‐methylguanine DNA methyltransferase (MGMT) expression in 117 cases of glioblastoma , 2014, Neuropathology : official journal of the Japanese Society of Neuropathology.
[9] M. Gariboldi,et al. Activity of temozolomide in patients with advanced chemorefractory colorectal cancer and MGMT promoter methylation. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[10] Jerry J. Lou,et al. Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome. , 2013, Neuro-oncology.
[11] E. Sausville,et al. A Phase II Study of Temozolomide in Patients with Advanced Aerodigestive Tract and Colorectal Cancers and Methylation of the O6-Methylguanine-DNA Methyltransferase Promoter , 2013, Molecular Cancer Therapeutics.
[12] M. Esteller,et al. Promoter CpG Island Hypermethylation of the DNA Repair Enzyme MGMT Predicts Clinical Response to Dacarbazine in a Phase II Study for Metastatic Colorectal Cancer , 2013, Clinical Cancer Research.
[13] Takashi Hirai,et al. Distinct profiles of epigenetic evolution between colorectal cancers with and without metastasis. , 2011, The American journal of pathology.
[14] Shuji Ogino,et al. MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancers , 2011, Cancer Causes & Control.
[15] A. Verma. MGMT Gene Silencing and Benefit From Temozolomide in Glioblastoma , 2006 .
[16] Gary L Rosner,et al. Tumour vasculature: On the verge of collapse , 2005, Nature Reviews Cancer.
[17] T. Mukai,et al. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island. , 2005, Journal of biochemistry.
[18] J. Herman,et al. Generating mutations but providing chemosensitivity: the role of O6-methylguanine DNA methyltransferase in human cancer , 2004, Oncogene.
[19] Scar,et al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. , 2000, The New England journal of medicine.
[20] J. Herman,et al. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. , 2000, Cancer research.